Science Explorer Interactive view Map
Company · Cambridge · ??

Cullinan Oncology (United States)

Research works
7
fractional, all time
Citations
43
6.2 per fractional work
Top-10% rate
12.0%
record average 16.5%
Open access
68%
world 28%

Not ranked overall: Cullinan Oncology (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Cullinan Oncology (United States) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Immunotherapy and Immune Responses and Immune Cell Function and Interaction.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  2. 2 CAR-T cell therapy research Oncology 1 works
  3. 3 Immunotherapy and Immune Responses Immunology 0 works
  4. 4 Immune Cell Function and Interaction Immunology 0 works
  5. 5 Cancer Research and Treatments Biotechnology 0 works
  6. 6 Biosimilars and Bioanalytical Methods Immunology 0 works
  7. 7 Cancer Immunotherapy and Biomarkers Oncology 0 works
  8. 8 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  9. 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  10. 10 Virus-based gene therapy research Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available67.5%not open32.5%

World: 28% of research is openly available.

with international co-authors19.3%domestic only80.7%

World: 19% is written across borders.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.